Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Hastatoside ameliorates alcohol-associated liver disease, potentially involving ATF4-regulated PANoptosis signaling cascades.

This study aimed to elucidate the therapeutic efficacy of Hastatoside (Has) against alcohol‑associated liver disease (ALD) and characterize the molecular mechanisms underlying its hepatoprotective effects. For in vivo studies, mice were fed a Lieber‑DeCarli ethanol diet for 28 days to establish ALD models, followed by...

Shuang Cao, Si-Yu Yuan, Yu-Han Jiang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.